Literature DB >> 14998514

The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection.

Manlio Di Cristina1, Paola Del Porto, Wilma Buffolano, Elisa Beghetto, Andrea Spadoni, Silvia Guglietta, Enza Piccolella, Franco Felici, Nicola Gargano.   

Abstract

Infection of humans by Toxoplasma gondii leads to an acute systemic phase, in which tachyzoites disseminate throughout the body, followed by a chronic phase characterized by the presence of tissue cysts, containing bradyzoites, in brain, heart and skeletal muscles. This work focused on studying the antigenic regions of bradyzoite-specific proteins involved in human B- and T-cell responses. To this aim, we constructed a phage-display library of DNA fragments derived from the bradyzoite-specific genes BAG1, MAG1, SAG2D, SAG4, BSR4, LDH2, ENO1 and p-ATPase. Challenge of the bradyzoite library with sera of infected individuals led to the identification of antigenic regions within BAG1 and MAG1 gene products. Analysis of the humoral and lymphoproliferative responses to recombinant antigens demonstrated that the BAG1 fragment induced T-cell proliferation in 34% of T. gondii-exposed individuals, while 50% of them had specific IgG. In the same subjects, the MAG1 fragment was recognized by T cells from 17% of the exposed donors and by antibodies from 73% of them. A detailed analysis of the antibody response against BAG1 and MAG1 antigen fragments demonstrated that the immune response against bradyzoites occurs early after infection in humans. Finally, we provide evidence that the T-cell response against BAG1 is associated with the production of interferon-gamma, suggesting that bradyzoite antigens should be considered in the design of potential vaccines in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998514     DOI: 10.1016/j.micinf.2003.11.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  24 in total

1.  Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis.

Authors:  M M Liu; Z G Yuan; G H Peng; D H Zhou; X H He; C Yan; C C Yin; Y He; R Q Lin; H Q Song; X Q Zhu
Journal:  Parasitol Res       Date:  2010-02-23       Impact factor: 2.289

2.  Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans.

Authors:  Lucyna Holec; Elzbieta Hiszczyńska-Sawicka; Artur Gasior; Anna Brillowska-Dabrowska; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

3.  Molecular and biochemical characterization of Toxoplasma gondii beta-hydroxyacyl-acyl carrier protein dehydratase (FABZ).

Authors:  George Dautu; Akio Ueno; Biscah Munyaka; Gabriella Carmen; Souichi Makino; Yoshiyasu Kobayashi; Makoto Igarashi
Journal:  Parasitol Res       Date:  2008-02-15       Impact factor: 2.289

4.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

5.  The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection.

Authors:  Jianchun Xiao; Raphael P Viscidi; Geetha Kannan; Mikhail V Pletnikov; Ye Li; Emily G Severance; Robert H Yolken; Laurence Delhaes
Journal:  Microbes Infect       Date:  2012-11-07       Impact factor: 2.700

6.  Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  Wilma Buffolano; Elisa Beghetto; Mariassunta Del Pezzo; Andrea Spadoni; Manlio Di Cristina; Eskild Petersen; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice.

Authors:  Pei-Yuan Wang; Zi-Guo Yuan; Eskild Petersen; Jie Li; Xiu-Xiang Zhang; Xiu-Zhen Li; Hao-Xin Li; Zhi-Cheng Lv; Tian Cheng; Di Ren; Gui-Lian Yang; Rui-Qing Lin; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

8.  Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice.

Authors:  Zi-Guo Yuan; Xiu-Xiang Zhang; Xian-Hui He; Eskild Petersen; Dong-Hui Zhou; Yong He; Rui-Qing Lin; Xiu-Zhen Li; Xu-Li Chen; Xiao-Ru Shi; Xiu-Ling Zhong; Bing Zhang; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

9.  Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay.

Authors:  Emmanuelle Chapey; Martine Wallon; Gisèle Debize; Muriel Rabilloud; François Peyron
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

10.  Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection.

Authors:  James Hester; Jeremi Mullins; Qila Sa; Laura Payne; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  Infect Immun       Date:  2012-07-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.